Euroscreen Awarded US Patent on P2Y13 (GPR86) Receptor
20th Sep 2005, 08:32 GMT
Euroscreen SA, today announced the issuance of a US patent which covers the use of a human G-protein-coupled receptor (GPCR) known as the human P2Y13. Euroscreens patent protects any screening process using this receptor in order to find compounds that modulate its activity, and thus may have pharmaceutical potential. [PRWEB Sep 20, 2005]